SARS Virus

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Allergy Therapeutics
Allergy TherapeuticsUK - West Sussex
1 program
Investigating Severe Acute Respiratory Syndrome (SARS)N/A1 trial
Active Trials
NCT00066209CompletedEst. May 2007

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Allergy TherapeuticsInvestigating Severe Acute Respiratory Syndrome (SARS)

Clinical Trials (1)

NCT00066209Allergy TherapeuticsInvestigating Severe Acute Respiratory Syndrome (SARS)

Investigating Severe Acute Respiratory Syndrome (SARS)

Start: Aug 2003Est. completion: May 2007
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space